👤 Xinhe Wu

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
1732
Articles
1210
Name variants
Also published as: Jiake Wu, Ming-Jiuan Wu, Siying Wu, Yijian Wu, Fong-Li Wu, Chih-Chung Wu, Jin'en Wu, D P Wu, Zhongwei Wu, Zixiang Wu, Haiping Wu, Geyan Wu, Qi-Zhu Wu, Jianjin Wu, Su Wu, Shwu-Yuan Wu, Xiaodi Wu, Changxin Wu, Kuen-Phon Wu, Guofeng Wu, Zhiping Wu, Xiaojun Wu, Qibing Wu, Xiaoting Wu, Cheng-Hsin Wu, Junhua Wu, Wenze Wu, Hong Wu, Yandi Wu, Zhong Wu, An-Chih Wu, Jianhui Wu, Xiaoke Wu, Zhenguo Wu, Jason H Y Wu, Bing-Bing Wu, Yi-Mi Wu, Selena Meiyun Wu, M Wu, Hui-Mei Wu, Danni Wu, Sijie Wu, Minqing Wu, Geng-ze Wu, Kun Wu, Cheng-Hua Wu, Shaofei Wu, Zhaoyang Wu, Qihan Wu, Kunling Wu, R Ryanne Wu, Mingxuan Wu, Pei Wu, Hao Wu, Wendy Wu, Yukang Wu, Jingtao Wu, Douglas C Wu, Guizhen Wu, Zhangjie Wu, Lili Wu, Jianwu Wu, Min-Jiao Wu, Biaoliang Wu, Huan Wu, Shengxi Wu, Fei-Fei Wu, Peih-Shan Wu, Yu-Yuan Wu, Guoqing Wu, Pei-Yu Wu, Lun-Gang Wu, Jing Wu, Geting Wu, Dongzhe Wu, G Wu, Junlong Wu, Jia-Jun Wu, Jiangyue Wu, Muzhou Wu, Junzhu Wu, Jian-Qiu Wu, Ray-Chin Wu, T Wu, Jianxiong Wu, Liping Wu, Haiwei Wu, Yong-Hao Wu, Guoping Wu, Jin-hua Wu, Yi Wu, Chongming Wu, You Wu, Qunzheng Wu, Xudong Wu, Liqiang Wu, Cuiling Wu, Kunfang Wu, Bian Wu, Limeng Wu, Jason Wu, Zhibing Wu, Shuying Wu, Caihong Wu, Naqiong Wu, Huating Wu, Joseph C Wu, Tianhao Wu, Zhi-Hong Wu, Congying Wu, Gaojun Wu, Dongping Wu, Chiao-En Wu, Li Wu, Yihang Wu, Shaoxuan Wu, Haixia Wu, Gen Wu, Fanchang Wu, Xiaorong Wu, Mei Wu, Jiahao Wu, Mingjie Wu, Jiapei Wu, Jia Wu, Lingqian Wu, Fangge Wu, Sen-Chao Wu, Yanhui Wu, Zhiqiang Wu, Sarah Wu, Shugeng Wu, Dongmei Wu, Xuanqin Wu, Caiwen Wu, Jiangdong Wu, Junjing Wu, Guihua Wu, Yingbiao Wu, Meini Wu, Rui Wu, Hua-Yu Wu, Bifeng Wu, Jingwan Wu, Lingling Wu, Junzheng Wu, Xinmiao Wu, Yi-Fang Wu, Yuyi Wu, Yixuan Wu, Leilei Wu, Qinglin Wu, Bin Wu, Tianqi Wu, Shiya Wu, Hui-Chen Wu, Jian Wu, Sijun Wu, Cong Wu, Yiwen Wu, Feng Wu, Xi-Ze Wu, Qiuji Wu, Alexander T H Wu, Qinan Wu, Semon Wu, Lai Man Natalie Wu, Zhuokai Wu, Panyun Wu, Ran Wu, Kui Wu, Yumei Wu, Xinrui Wu, Yueling Wu, Biwei Wu, Xing Wu, Jiayi Wu, Hua Wu, Bingjie Wu, Yuen-Jung Wu, Xiaoliang Wu, Matthew A Wu, Jin Wu, Juanjuan Wu, Qiuhong Wu, Hongfu Wu, Xiaoming Wu, Ming-Sian Wu, Ronghua Wu, Junduo Wu, Dandan Wu, Ming-Shiang Wu, Yuliang Wu, Ying-Ying Wu, Chaoling Wu, Guang-Liang Wu, De Wu, Yuanyuan Wu, Yihua Wu, Tsung-Jui Wu, Yulian Wu, Han Wu, Lipeng Wu, Zhihao Wu, Jiexi Wu, Anna H Wu, Qiu Wu, Huazhen Wu, Yaqin Wu, Shengru Wu, Chieh-Lin Stanley Wu, Xiaoqian Wu, Xiahui Wu, Jian-Yi Wu, Jianli Wu, Yun-Wen Wu, Qiuya Wu, Tsai-Kun Wu, Xinyin Wu, Guoyao Wu, Zhenfeng Wu, Guoli Wu, J W Wu, Bill X Wu, Zujun Wu, Jianliang Wu, Yuanshun Wu, Ling-Ying Wu, Zeng-An Wu, Jianrong Wu, Xue Wu, Ke Wu, Mengxue Wu, Cheng-Yang Wu, Jinghong Wu, Rongrong Wu, Ruolan Wu, Rong Wu, Kevin Zl Wu, Xiaohong Wu, Run Wu, Zaihao Wu, Chaowei Wu, Yu-Ke Wu, Xinjing Wu, Anyue Wu, Meili Wu, Shu Wu, Yun Wu, Xuan Wu, Wanxia Wu, Yi-No Wu, Chao-Liang Wu, Chengwei Wu, Y-W Wu, Pensee Wu, Zhao-Bo Wu, Guangxian Wu, Xiao Wu, Juanli Wu, Xinlei Wu, Changjie Wu, Sai Wu, Jiawei Wu, Yujuan Wu, Haoze Wu, Renlv Wu, Xiaoyang Wu, Yipeng Wu, Yuh-Lin Wu, Yu'e Wu, Dan-Chun Wu, An-Hua Wu, Meng-Chao Wu, Yuanhao Wu, Jer-Yuarn Wu, Qian-Yan Wu, Guangyan Wu, Huisheng Wu, Huijuan Wu, Shuting Wu, Long-Jun Wu, Alice Ying-Jung Wu, Xiru Wu, Zhenfang Wu, Lidi Wu, Yetong Wu, Disheng Wu, Linmei Wu, Huiwen Wu, Zhenzhou Wu, Yuhong Wu, Liang Wu, Liyan Wu, Kuan-Li Wu, Pei-Ting Wu, Xiao-Jin Wu, Lifeng Wu, Terence Wu, Shujuan Wu, Gang Wu, Xue-Mei Wu, Szu-Hsien Wu, Yan-ling Wu, Yih-Jer Wu, Xiaokang Wu, Lingyan Wu, Xinghua Wu, Chunfu Wu, Yingxia Wu, Rongling Wu, Xifeng Wu, Jinhua Wu, Sihan Wu, Ming-Yue Wu, Shiyang Wu, K D Wu, Luyan Wu, Jinmei Wu, Shin-Long Wu, Shuai Wu, Zhipeng Wu, Zhixiang Wu, Guangzhen Wu, Longting Wu, Zhengsheng Wu, Xiaoqiong Wu, Yaoxing Wu, Yuqin Wu, Yudan Wu, Hongting Wu, Zoe Wu, Chi-Jen Wu, R Wu, Zhongqiu Wu, Meina Wu, Anke Wu, Dengying Wu, Cheng-Jang Wu, Hsi-Chin Wu, Shufang Wu, Yongjiang Wu, Yuan-de Wu, Sihui Wu, Qi Wu, Wenhui Wu, Fenfang Wu, K S Wu, Nana Wu, Jianzhi Wu, Lin-Han Wu, Zhen Wu, Jinjun Wu, Chen-Lu Wu, Jing-Fang Wu, Haiyan Wu, Yihui Wu, Qiqing Wu, Zhengzhi Wu, Dai-Chao Wu, Zhenyan Wu, Wen-Jeng Wu, Sean M Wu, Guanming Wu, Yongqun Wu, Hei-Man Wu, Su-Hui Wu, Diana H Wu, Ben J Wu, Pingxian Wu, Chew-Wun Wu, Yillin Wu, Xiaobing Wu, Jiang-Bo Wu, Jerry Wu, Siming Wu, Zijun Wu, Daqing Wu, Yu-Hsuan Wu, Lichao Wu, Zhimin Wu, Qijing Wu, Daxian Wu, Zhaoyi Wu, Z Wu, Tong Wu, Shusheng Wu, Cheng-Chun Wu, Tracy Wu, D Wu, Ting-Ting Wu, Xiao-Yan Wu, J Wu, Lan Wu, Changchen Wu, Qi-Fang Wu, Changwei Wu, Liangyan Wu, Liufeng Wu, Kan Wu, Eugenia Wu, Mingming Wu, Xiaolong Wu, Chunru Wu, Zhaofei Wu, Shenhao Wu, Li-Peng Wu, Yuna Wu, Minna Wu, Justin Che-Yuen Wu, Buling Wu, Chengyu Wu, Wutian Wu, Yuwei Wu, Guixin Wu, Haijing Wu, Hei Man Wu, Qiuchen Wu, Junfei Wu, Xiao-Hui Wu, Linyu Wu, Wenda Wu, Xiaofeng Wu, Yung-Fu Wu, Mengbo Wu, Zhenling Wu, Maoqing Wu, Zuping Wu, Chun-Chieh Wu, Julian Wu, Binbin Wu, Xiaohui Wu, Qian Wu, Xinchun Wu, Shuisheng Wu, Linxiang Wu, Xueqing Wu, Bo Wu, Moxin Wu, Xiao-Cheng Wu, Anzhou Wu, Shuyi Wu, Jiahui Wu, Meiqin Wu, Shihao Wu, Jer-Yuan Wu, Wen-Shu Wu, Wudelehu Wu, Ruonan Wu, Song Wu, De-Fu Wu, Yulin Wu, Hongyu Wu, Yurong Wu, Zixuan Wu, Shih-Ying Wu, Chih-Hsing Wu, Chengrong Wu, Yinghao Wu, Yuanzhao Wu, Wenjie Wu, Baochuan Wu, Ziliang Wu, Liuting Wu, Chia-Ling Wu, Y Q Wu, Man Wu, Na Wu, Wutain Wu, Chenyang Wu, Jinyu Wu, Selwin K Wu, Ping Wu, Lorna Wu, D I Wu, Yi-Cheng Wu, Jianzhong Wu, Xiaoyun Wu, Zhourui Wu, Li-Jun Wu, Zhi-Wei Wu, Yinan Wu, Xinyan Wu, Xin Wu, Yawei Wu, Shixin Wu, Ting-Feng Wu, Hong-Mei Wu, Xiaojin Wu, Yiqun Wu, Tsung-Teh Wu, Jiarui Wu, Qi-Nian Wu, Ju Wu, Kai-Yue Wu, Pengjie Wu, Xi-Chen Wu, Zhe Wu, Shaoping Wu, Zhou Wu, Han-Jie Wu, Haijiang Wu, Weijie Wu, Xiaojie Wu, Hongfei Wu, Zhentian Wu, Yi-Ying Wu, Ze Wu, Kai-Hong Wu, Yuting Wu, Minyao Wu, Xueyan Wu, Shinan Wu, Feifei Wu, Yonghui Wu, Haoxuan Wu, Yanzhi Wu, Yiyi Wu, Guohao Wu, Dong Wu, Shibo Wu, Wenjing Wu, Wenqian Wu, Tian Wu, Tiantian Wu, Hai-Yan Wu, Chong Wu, Hongxian Wu, Daoyuan Wu, Zongfu Wu, Ling Wu, Yuxiang Wu, Xilong Wu, Yuyu Wu, Zong-Jia Wu, Fengming Wu, Huijian Wu, Guorong Wu, Chuanhong Wu, Choufei Wu, Chi-Chung Wu, Junfang Wu, Xingwei Wu, Xiaoqing Wu, Ling-Fei Wu, Xinyang Wu, Xiaomin Wu, Yili Wu, Hong-Fu Wu, Shao-Ming Wu, Thomas D Wu, Lizhen Wu, Yuanming Wu, Hsien-Ming Wu, Jian Hui Wu, Litong Wu, Yuxian Wu, Weihua Wu, Lei Wu, C Wu, Wei Wu, Yu-E Wu, Qiulian Wu, Mei-Hwan Wu, Yuexiu Wu, Shaoze Wu, Zilong Wu, Chi-Hao Wu, Baojin Wu, Chao Wu, Yao Wu, Ya Wu, Do-Bo Wu, Wenjun Wu, Zhongren Wu, Nini Wu, Michael C Wu, Ning Wu, Ming J Wu, Jie Wu, Yi-Syuan Wu, Zhenzhen Wu, Limei Wu, Wen-Chieh Wu, Tianwen Wu, Junfeng Wu, Shunan Wu, Yunhua Wu, Junqi Wu, Honglin Wu, Jianing Wu, Maureen Wu, Yexiang Wu, Yan-Hua Wu, Mengjun Wu, Y H Wu, Mingxing Wu, Liuying Wu, Suhua Wu, Xiaomeng Wu, Shyh-Jong Wu, Tung-Ho Wu, Hongliang Wu, Wenxian Wu, Ed Xuekui Wu, Xuekun Wu, Wenqiang Wu, Chuang Wu, Jingyi Wu, Duojiao Wu, Xueyuan Wu, Ji-Zhou Wu, Lianqian Wu, Gaige Wu, Qing-Qian Wu, Haihu Wu, Xiushan Wu, Xueyao Wu, Tingchun Wu, Yafei Wu, Lingxi Wu, R-J Wu, Weidong Wu, Re-Wen Wu, Zhidan Wu, Peiyao Wu, Xuemei Wu, Chen Wu, Yiting Wu, Kerui Wu, Lihong Wu, Shiqi Wu, Liren Wu, Xiuhua Wu, Beili Wu, Yongqi Wu, Ruihong Wu, Huini Wu, Guang-Long Wu, Lingyun Wu, Po-Chang Wu, Wenxue Wu, Ru-Zi Wu, Qinghua Wu, Changjing Wu, Wenlin Wu, Xiexing Wu, J Y Wu, Jianping Wu, Guanggeng Wu, Zhichong Wu, W J Wu, Di Wu, Shaoyu Wu, Xiaotong Wu, Junyong Wu, Hui Wu, Shengde Wu, Hongyan Wu, Mengyuan Wu, Yutong Wu, Zheming Wu, Yiping Wu, Guiping Wu, Wen-Hui Wu, Dapeng Wu, Bing Wu, Wen-Sheng Wu, Yunpeng Wu, Li-Ling Wu, Xiao-Yuan Wu, Baiyan Wu, Qiu-Li Wu, Xiao-Ye Wu, Ying Wu, Da-Hua Wu, Hsing-Chieh Wu, Hui-Xuan Wu, Chieh-Jen Wu, Pengning Wu, Sichen Wu, S F Wu, Mengying Wu, Ming-Der Wu, Jia-En Wu, Weida Wu, Guo-Chao Wu, Qi-Jun Wu, Zhenyong Wu, Qi-Biao Wu, Yangfeng Wu, Lijie Wu, Zhiye Wu, Jihui Wu, JieQian Wu, Zhengliang L Wu, Qianqian Wu, Jingyun Wu, Xiaoman Wu, Ruohao Wu, Yiyang Wu, Zhengfeng Wu, Xiao-Jun Wu, Lizi Wu, Qiang Wu, Riping Wu, J-Z Wu, Guangjie Wu, Pengfei Wu, Jundong Wu, Beier Wu, Jianying Wu, Meng-Ling Wu, Lingxiang Wu, Jamie L Y Wu, Keija Wu, Xilin Wu, Yanhua Wu, An-Li Wu, Yi-Ming Wu, Chengbiao Wu, Huanghui Wu, Dong-Feng Wu, Kunsheng Wu, Zhengcan Wu, Yuxin Wu, Kun-Rong Wu, Guanxian Wu, Dong-Fang Wu, Sensen Wu, Guifen Wu, Yifeng Wu, Tzu-Chun Wu, Pin Wu, Qingping Wu, Mian Wu, R M Wu, S J Wu, Haisu Wu, Senquan Wu, Jingjing Wu, Cheng Wu, Meng Wu, Geping Wu, Yu Wu, Yumin Wu, Xia Wu, William Ka Kei Wu, Xian-Run Wu, Juan Wu, Meng-Hsun Wu, Pei-Ei Wu, Yingying Wu, S M Wu, Xiangwei Wu, Guangrun Wu, Liuxin Wu, Yangyu Wu, Jia-Hui Wu, Jin-Zhen Wu, Shaohuan Wu, S L Wu, Yanli Wu, June K Wu, Haishan Wu, H Wu, Zhou-Ming Wu, Deqing Wu, Tao Wu, Dong-Bo Wu, Binxin Wu, Yalan Wu, Xiangxin Wu, Xueji Wu, Hongxi Wu, Zhonghui Wu, Jiaxi Wu, Tianzhi Wu, Meiqi Wu, Weiwei Wu, Yan-Jun Wu, Lijuan Wu, Tingqin Wu, Jianming Wu, P L Wu, Yih-Ru Wu, Jianjun Wu, Lanlan Wu, An-Xin Wu, Jianguang Wu, Xingjie Wu, Jianzhang Wu, Xianan Wu, Wei-Ping Wu, Fang-Tzu Wu, Haoan Wu, Wenwen Wu, Zhongjun Wu, Xi Wu, Teng Wu, Xiaoling Wu, Mengjuan Wu, Wen Wu, Yifan Wu, Yang Wu, Qianhu Wu, Wu-Tian Wu, Shenyue Wu, Qianwen Wu, Ye Wu, Gui-Qin Wu, Lixing Wu, Grace F Wu, Xing-Ping Wu, Ming Wu, Lisha Wu, Yanchuan Wu, Siqi Wu, Yuming Wu, Yuan Wu, Yu-Ting Wu, I H Wu, Hailong Wu, Minghua Wu, B Wu, Zhenlong Wu, Fang Wu, Guanzhong Wu, Liqun Wu, Guifu Wu, Chris Y Wu, Zhikang Wu, Qi-Yong Wu, Qingshi Wu, Zhao-Yang Wu, Man-Jing Wu, Chih-Ching Wu, Jun Wu, Jinhui Wu, Jincheng Wu, Linhong Wu, Hung-Tsung Wu, Tangchun Wu, Xinglong Wu, Zhen-Yang Wu, Ma Wu, Yin Wu, Jiu-Lin Wu, Dongyan Wu, Yong Wu, Yan Wu, Weizhen Wu, Changyu Wu, Fanggeng Wu, Dishan Wu, Yue Wu, Yi-Long Wu, Ge-ru Wu, Jinqiao Wu, Jing-Wen Wu, Zhongyang Wu, Lifang Wu, Songfen Wu, Jia-Wei Wu, Sheng-Li Wu, Yihan Wu, Kebang Wu, Wenyong Wu, Cai-Qin Wu, Yilong Wu, Yanan Wu, Hsiu-Chuan Wu, Xueqian Wu, Yen-Wen Wu, Paul W Wu, Ying-Ting Wu, Xing-De Wu, Mingfu Wu, Yucan Wu, Na-Qiong Wu, Linzhi Wu, Jinze Wu, Xuhan Wu, H J Wu, Dirong Wu, Ruize Wu, Chung-Yi Wu, Yaohong Wu, Jianyi Wu, Jugang Wu, Jiao Wu, Liang-Huan Wu, Xueling Wu, Ruying Wu, Gen Sheng Wu, Zhaoyuan Wu, Shiwen Wu, Andong Wu, Yu-Ling Wu, Hsan-Au Wu, Jia-Qi Wu, Yanting Wu, Xihai Wu, Lulu Wu, Xuxian Wu, Xiaomei Wu, Jingyue Wu, Shuihua Wu, Ren Wu, S Wu, Haoming Wu, Yupeng Wu, Samuel M Wu, Fan Wu, Yuesheng Wu, Yihe Wu, Tiange Wu, Shuang Wu, Jiayu Wu, Chia-Lung Wu, Yaojiong Wu, Shengnan Wu, Y Y Wu, Zhuoze Wu, Y Wu, Zimu Wu, Depei Wu, Yi-Hua Wu, Haiyun Wu, Yanyan Wu, Min Wu, Wenjuan Wu, Jinfeng Wu, Guangxi Wu, Junjie Wu, Yawen Wu, Pinglian Wu, Hui-Hui Wu, Xunwei Wu, Xuefeng Wu, Depeng Wu, Constance Wu, Dianqing Wu, Qibiao Wu, Nan Wu, Hao-Tian Wu, Hanyu Wu, Xiaojiang Wu, Cheng-Jun Wu, San-pin Wu, Xiaofan Wu, Xiwei Wu, Shi-Xin Wu, Shao-Guo Wu, Sunyi Wu, Yueheng Wu, Chengqian Wu, Kuixian Wu, Xin-Xi Wu, Guanyi Wu, Qiuxia Wu, Danhong Wu, Zhong-Jun Wu, Siyi Wu, He Wu, Xiangsheng Wu, Lanxiang Wu, Kaili Wu, Liting Wu, Ping-Hsun Wu, Zheng Wu, Wen-Ling Wu, Jiang-Nan Wu, Huanlin Wu, Yongfei Wu, Catherine A Wu, Leslie Wu, Shuo Wu, Peng-Fei Wu, Cho-Kai Wu, Meng-Han Wu, Hon-Yen Wu, Yuguang Philip Wu, Anguo Wu, Hai-Yin Wu, Yicheng Wu, Xiaolang Wu, Yujie Wu, Qing Wu, V C Wu, Haomin Wu, Xingdong Wu, Hengyu Wu, Jiang Wu, Xiaoli Wu, Chengxi Wu, Junyi Wu, Ling-qian Wu, William K K Wu, Chun Wu, Lesley Wu, Niting Wu, Jiayuan Wu, Xueying Wu, Yingning Wu, S-F Wu, David Wu, Mei-Na Wu, Joshua L Wu, Jin-Shang Wu, Guanzhao Wu, Jianqiang Wu, Runda Wu, Li-Hsien Wu, June-Hsieh Wu, Rongjie Wu, Huazhang Wu, Huanwen Wu, Xiu-Zhi Wu, Xianfeng Wu, Yanran Wu, Weibin Wu, Xuanshuang Wu, G X Wu, Yan Yan Wu, Runpei Wu, Jiaqi Wu, Chien-Ting Wu, Li-Na Wu, Qinfeng Wu, Chia-Chang Wu, Yueming Wu, Renhai Wu, Siyu Wu, Baojian Wu, Yi-Xia Wu, Wei-Yin Wu, Renrong Wu, C-H Wu, Chuan-Ling Wu, Xinran Wu, Fengying Wu, Qiuliang Wu, Guanhui Wu, Jinjie Wu, Wei-Chi Wu, Wei-Xun Wu, Meng-Na Wu, Lin Wu, Wan-Fu Wu, Jiajing Wu, Colin Chih-Chien Wu, Yajie Wu, Qiaowei Wu, Yaru Wu, Xiaoping Wu, Xue-Yan Wu, Weijun Wu, Mengchao Wu, Boquan Wu, Chunyan Wu, Zelai Wu, Pei-Wen Wu, Guojun Wu, Yichen Wu, Ming-Tao Wu, Hsueh-Erh Wu, Guang-Bo Wu, Zhi-Yong Wu, Chia-Zhen Wu, Kay L H Wu, Yong-Hong Wu, Anping Wu, Jiahang Wu, Xiaobin Wu, Ching-Yi Wu, Linzhen Wu, Xiaoxing Wu, Haidong Wu, Zhen-Qi Wu, Mark N Wu, Jianmin Wu, Xianpei Wu, Guanrong Wu, Dongsheng Wu, Yanchun Wu, An-Dong Wu, Ren-Chin Wu, Yuchen Wu, Mengna Wu, Lijun Wu, Zhuanbin Wu, Yanjing Wu, Lun Wu, Haodi Wu, Si-Jia Wu, Yongfa Wu, Ximei Wu, Hai-Ping Wu, Wenyu Wu, Xiangping Wu, L-F Wu, Yixia Wu, Haiying Wu, Yiran Wu, Yanhong Wu, Xiayin Wu, Yushun Wu, Yali Wu, Qitian Wu, Qin Wu, Xiaofu Wu, Jiamei Wu, Xiaoyong Wu, Qiong Wu, Xiaoying Wu, Wujun Wu, N Wu, Peiyi Wu, Yongmei Wu, Xiaojing Wu, Yizhou Wu, Dan Wu, Wen-Qiang Wu, Anshi Wu, Junqing Wu, Xiao-Yang Wu, Zhaoxia Wu, Liyang Wu, Hongke Wu, Mengqiu Wu, Peng Wu, Haibin Wu, Ding Lan Wu, Lecheng Wu, Yingzhi Wu, Kejia Wu, Anyi Wu, Junshu Wu, Jianxin Wu, Deguang Wu, Jiaxuan Wu, W Wu, Justin C Y Wu, Jiong Wu, Yu-Chih Wu, Xinyi Wu, Qinglan Wu, Diana Wu, Zhongluan Wu, Xuefen Wu, Yanqiong Wu, Shengming Wu, Jian-Lin Wu, Donglin Wu, Daren Wu, Lintao Wu, Xiaodong Wu, Chang-Jiun Wu, Chunshuai Wu, Irene X Y Wu, Yaping Wu, Yangna Wu, Xiping Wu, Zongheng Wu, Chia-Chen Wu, Wenyi Wu, Yansheng Wu, Shaojun Wu, Aimin Wu, Caisheng Wu, Xu Wu, Zhongchan Wu, Fei Wu, Yaohua Wu, Qinyi Wu, Yibo Wu, Zhengyu Wu, Yadi Wu, Hang Wu, L Wu, Mingjun Wu, Yuetong Wu, Wen-Juan Wu, Guangming Wu, Lingzhi Wu, Tingting Wu, Zhong-Yan Wu, Zhuzhu Wu, Yuanbing Wu, Cuiyan Wu, Colin O Wu, Baoqin Wu, Shuyan Wu, Hongmei Wu, Guangsen Wu, Xiaolin Wu, An Guo Wu, Kailang Wu, Chien-Sheng Wu, Chun-Hua Wu, Jemma X Wu, Wenqi Wu, Quanhui Wu, Qing-Wu Wu, Yanxiang Wu, Jiajin Wu, Qiao Wu, Yuan Kai Wu
articles
Zhi Wang, Qiao Wu, Hongzhan Wang +8 more · 2022 · Phytomedicine : international journal of phytotherapy and phytopharmacology · Elsevier · added 2026-04-24
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus. DN is the main cause of end-stage renal disease (ESRD). SIRT6 becomes the important target of DN. Diosgenin (a monomer from Ch Show more
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus. DN is the main cause of end-stage renal disease (ESRD). SIRT6 becomes the important target of DN. Diosgenin (a monomer from Chinese herbs) is probable to bind to SIRT6. Based on studies presented in the literature on kidney injuries plus screening for the binding effects of the drug to Sirt6, we aimed to carry out the study to assess the effects of diosgenin involved in improving podocyte damage in the early phase of DN.. DN model was established in spontaneous diabetic db/db mice. Animal experiment was in two parts. The first part includes four groups consisting of control (Con) group, model (Mod) group, low dose of diosgenin (DL) group and high dose of diosgenin (DH) group. The second part includes four groups consisting of control group, model group, DH+OSS₁₂₈₁₆₇ (OSS, inhibitor of SIRT6) group, MDL800 (agonist of SIRT6) group. MPC5 cell line was selected in cell experiment, which was mainly composed of six groups including Con group, palmitic acid (PA) group, PA+DL group, PA+DH group, PA+DH+OSS group, PA+MDL800 group. Some procedures such as transcriptomics, RT-qPCR and so on were used in the study to explore and verify the mechanism. The abnormal changes of mesangial matrix expansion, glomerular basement membrane (GBM) thickness, foot process (FP) width, urine albumin/creatinine (UACR), DESMIN, ADRP, NEPHRIN, PODOCIN, SIRT6 in Mod group were alleviated in DH group rather than DL group in the first part of animal experiment. The effect in DH group could be reversed in DH+OSS group and the same effect was observed in MDL800 group in the second part of animal experiment. The same results were also found in cell experiment. Protein level and mRNA expression of pyruvate dehydrogenase kinase 4 (PDK4) and Angiopoietin-like-4 (ANGPTL4) were increased in PA group, which could be alleviated in DH group, MDL800 group rather than DH+OSS group. Diosgenin could protect against podocyte injury in early phase of diabetic nephropathy by regulating SIRT6. Show less
no PDF DOI: 10.1016/j.phymed.2022.154276
ANGPTL4
Fen Zhang, Jie Wu, Xingxing Li +3 more · 2022 · Nursing & health sciences · Blackwell Publishing · added 2026-04-24
Bone marrow-derived mesenchymal stem cells (BMSCs) and their exosomes are of great significance for the recovery of cardiac function in patients with myocardial infarction (MI). However, the underlyin Show more
Bone marrow-derived mesenchymal stem cells (BMSCs) and their exosomes are of great significance for the recovery of cardiac function in patients with myocardial infarction (MI). However, the underlying mechanisms of BMSCs applied to MI treatment remain unclear. Fluorescence-activated cell sorting (FACs) are performed to assess the apoptosis, reactive oxygen species levels and glucose uptake capacity of BMSCs. Reverse transcription polymerase chain reaction is conducted to detect the levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), transforming growth factor-beta 1, connective tissue growth factor, and platelet-derived growth factor. The levels of apoptosis-related proteins were detected by Western blot. The levels of VEGF, bFGF, HGF, and IGF were assessed by enzyme-linked immunosorbent assay. The biochemical kits are applied to detect the levels of malondialdehyde, superoxide dismutase, and adenosine triphosphate/adenosine diphosphate. 2,3,5-triphenyltetrazolium and Masson staining and immunofluorescence are performed to assess myocardial function of rats. Angiopoietin-like protein 4 (ANGPTL4) alleviates apoptosis and oxidative stress of BMSCs induced by serum deprivation and hypoxia; ANGPTL4 activates paracrine and accelerate metabolic energy of BMSCs; and ANGPTL4 treated-BMSCs alleviate myocardial injury of rats with MI. ANGPTL4 treated-BMSCs alleviate myocardial injury in rats with MI, indicating the combination therapy of ANGPTL4 and BMSCs may alleviate myocardial injury in rats with MI. Show less
📄 PDF DOI: 10.1111/nhs.12927
ANGPTL4
Qing Xu, Chaoju Gong, Lei Qiao +7 more · 2022 · Journal of diabetes research · added 2026-04-24
To investigate the aqueous levels of angiogenic factors in nonproliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME) and to ascertain their association with optical coher Show more
To investigate the aqueous levels of angiogenic factors in nonproliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME) and to ascertain their association with optical coherence tomography angiography (OCTA) metrics. This study enrolled 21 NPDR eyes with DME (NPDR/DME+), 17 NPDR eyes without DME (NPDR/DME-), and 16 diabetic eyes without retinopathy (DWR). Luminex bead-based multiplex array was used to measure the levels of 25 cytokines. OCTA system with a scan area of 3 × 3 mm was used to measure retinal thickness (RT), retinal volume (RV), superficial vessel density (SVD), deep vessel density (DVD), foveal avascular zone (FAZ) area, perimeter and acircularity index. The levels of ANGPTL4 were significantly different among the three groups ( The level of ANGPTL4 in aqueous humor of NPDR patients with DME was significantly increased and ANGPTL4 might predict RT, RV, and parafoveal DVD of DME in NPDR patients. Show less
📄 PDF DOI: 10.1155/2022/8435603
ANGPTL4
Yu He, Ning Liu, Yun Ji +2 more · 2022 · The Journal of nutrition · Oxford University Press · added 2026-04-24
In vivo data on intestinal fat absorption in weanling piglets are scarce. This study aimed to investigate the effect of weaning stress on intestinal fat absorption. Eighteen 7-d-old sow-reared piglets Show more
In vivo data on intestinal fat absorption in weanling piglets are scarce. This study aimed to investigate the effect of weaning stress on intestinal fat absorption. Eighteen 7-d-old sow-reared piglets (Duroc-Landrace-Yorkshire) were assigned to 3 groups (n = 6/group, 3 males and 3 females per group). Piglets were nursed by sows until 24 d of age (suckling piglets, S), or weaned at 21 d of age to a corn-soybean meal-based diet until 24 d (3 d postweaning, W3) or 28 d (7 d postweaning, W7) of age, respectively. Duodenum, jejunum, and ileum were collected to determine intestinal morphology and abundance of proteins related to fat absorption. Compared with the S group, the W3 group had lower villus height (17-34%) and villus height to crypt depth ratio (13-53%), as well as 1-1.45 times greater crypt depth; these values were 1.18-1.31, 0.69-1.15, and 1.47-1.87 times greater in the W7 group than in the W3 group, respectively. Compared with the S group, weaning stress for both W3 and W7 groups reduced intestinal alkaline phosphatase activity (26-73%), serum lipids (26-54%), and abundances of proteins related to fatty acid transport [fatty acid transport protein 4 (FATP4) and intestinal fatty acid-binding protein (I-FABP)] and chylomicron assembly [microsomal triglyceride transfer protein (MTTP), apolipoprotein A-IV (APOA4), B (APOB), and A-I (APOA1)] in the duodenum and ileum (10-55%), as well as in the jejunum (25-85%). All these indexes did not differ between W3 and W7 groups. Compared with the S group, the W3 group had lower mRNA abundances of duodenal APOA4 and APOA1 (25-50%), as well as jejunal FATP4, IFABP, MTTP, APOA4, and APOA1 (35-50%); these values were 5-15% and 10-37% lower in the W7 group than in the W3 group, respectively. Weaning stress in piglets attenuates the expression of intestinal proteins related to fatty acid transport (FATP4 and I-FABP) and chylomicron synthesis (APOA4). Show less
no PDF DOI: 10.1093/jn/nxac177
APOA4
Xuexiu Liu, Xianhong Zhang, Luquan Li +3 more · 2022 · BMC pediatrics · BioMed Central · added 2026-04-24
To detect differentially expressed genes in patients with neonatal necrotizing enterocolitis (NEC) by bioinformatics methods and to provide new ideas and research directions for the prevention, early Show more
To detect differentially expressed genes in patients with neonatal necrotizing enterocolitis (NEC) by bioinformatics methods and to provide new ideas and research directions for the prevention, early diagnosis and treatment of NEC. Gene chip data were downloaded from the Gene Expression Omnibus database. The genes that were differentially expressed in NEC compared with normal intestinal tissues were screened with GEO2R. The functions, pathway enrichment and protein interactions of these genes were analyzed with DAVID and STRING. Then, the core network genes and significant protein interaction modules were detected using Cytoscape software. Overall, a total of 236 differentially expressed genes were detected, including 225 upregulated genes and 11 downregulated genes, and GO and KEGG enrichment analyses were performed. The results indicated that the upregulated differentially expressed genes were related to the dimerization activity of proteins, while the downregulated differentially expressed genes were related to the activity of cholesterol transporters. KEGG enrichment analysis revealed that the differentially expressed genes were significantly concentrated in metabolism, fat digestion and absorption pathways. Through STRING analysis, 9 key genes in the protein network interaction map were identified: EPCAM, CDH1, CFTR, IL-6, APOB, APOC3, APOA4, SLC2A and NR1H4. Metabolic pathways and biological processes may play important roles in the development of NEC. The screening of possible core targets by bioinformatics is helpful in clarifying the pathogenesis of NEC at the gene level and in providing references for further research. Show less
📄 PDF DOI: 10.1186/s12887-022-03721-4
APOA4
Guiping Wu, Zhenhui Li, Yun Zheng +4 more · 2022 · Poultry science · Elsevier · added 2026-04-24
The effects of cholamine, a raw material for synthesis of some active lipids, are unknown in poultry. To address this, 180 52-wk-old Hyline laying hens were randomly divided into 3 groups (20 replicat Show more
The effects of cholamine, a raw material for synthesis of some active lipids, are unknown in poultry. To address this, 180 52-wk-old Hyline laying hens were randomly divided into 3 groups (20 replicates per group with three hens per replicate). The control group and the treatment groups (treatment 1 and 2) were fed basal diet and the diet supplemented with 500 or 1,000 mg of cholamine per kilogram of the diet for 35 d, respectively. The data showed that supplementary cholamine significantly lowered egg production, daily feed intake, serum high-density lipoprotein cholesterol level, liver index, and the percentages of C15:0 and C20:0 in fatty acid composition of liver, significantly elevated hepatic triglyceride content, the ratio of villus height to crypt depth (P < 0.05), and the percentage of C18:2n-6 and the ratio of n-6 to n-3 polyunsaturated fatty acids in liver fat (P < 0.10). Moreover, supplementary cholamine altered the relative abundance of some intestinal bacteria with a decrease in the alpha biodiversity (P < 0.10). Additionally, transcriptome analysis on the livers of the treatment vs. the control groups identified 1,151 up- and 914 down-regulated differentially expressed genes (DEGs), and pathway analysis revealed that the suppressed Notch signaling pathway and the enhanced Oxidative phosphorylation pathway were enriched with DEGs. Particularly, fat absorption, transport and oxidative phosphorylation-related DEGs (e.g., FABP1, APOA4, and PCK1) were significantly induced, but fatty acid synthesis, and lipid package and secretion-related DEGs (e.g., FASN, SCD, and MTTP) were not. In conclusion, supplementary cholamine may lower egg production by promoting hepatic lipid deposition and reducing abundances of beneficial intestinal bacteria and microfloral biodiversity in laying hens. Show less
📄 PDF DOI: 10.1016/j.psj.2022.102084
APOA4
Huiling Lai, Yunyun Guo, Liming Tian +8 more · 2022 · Cancers · MDPI · added 2026-04-24
Although ovarian cancer, a gynecological malignancy, has the highest fatality rate, it still lacks highly specific biomarkers, and the differential diagnosis of ovarian masses remains difficult to det Show more
Although ovarian cancer, a gynecological malignancy, has the highest fatality rate, it still lacks highly specific biomarkers, and the differential diagnosis of ovarian masses remains difficult to determine for gynecologists. Our study aimed to obtain ovarian cancer-specific protein candidates from the circulating small extracellular vesicles (sEVs) and develop a protein panel for ovarian cancer screening and differential diagnosis of ovarian masses. In our study, sEVs derived from the serum of healthy controls and patients with cystadenoma and ovarian cancer were investigated to obtain a cancer-specific proteomic profile. In a discovery cohort, 1119 proteins were identified, and significant differences in the protein profiles of EVs were observed among groups. Then, 23 differentially expressed proteins were assessed using the parallel reaction monitoring in a validation cohort. Through univariate and multivariate logistic regression analyses, a novel model comprising three proteins (fibrinogen gamma gene (FGG), mucin 16 (MUC16), and apolipoprotein (APOA4)) was established to screen patients with ovarian cancer. This model exhibited an area under the receiver operating characteristic curve (AUC) of 0.936 (95% CI, 0.888-0.984) with 92.0% sensitivity and 82.9% specificity. Another panel comprising serum CA125, sEV-APOA4, and sEV-CD5L showed excellent performance (AUC 0.945 (95% CI, 0.890-1.000), sensitivity of 88.0%, specificity of 93.3%, and accuracy of 89.2%) to distinguish malignancy from benign ovarian masses. Altogether, our study provided a proteomic signature of circulating sEVs in ovarian cancer. The diagnostic proteomic panel may complement current clinical diagnostic measures for screening ovarian cancer in the general population and the differential diagnosis of ovarian masses. Show less
📄 PDF DOI: 10.3390/cancers14153719
APOA4
Xianjiu Liao, Caiyi Zhang, Shang Qiu +7 more · 2022 · Talanta · Elsevier · added 2026-04-24
A new label-free method was developed for SERS detection of human apolipoprotein A4. Rolling circle amplification (RCA) was used, which could induce the production of AuNPs (poly adenine and adsorptio Show more
A new label-free method was developed for SERS detection of human apolipoprotein A4. Rolling circle amplification (RCA) was used, which could induce the production of AuNPs (poly adenine and adsorption gold nanoparticles). When there were two DNA labeled antibodies and target protein, MB1 (molecular beacon 1) was unfolded and the substrate was modified in the homogeneous solution, and the proximate complex was formed. The unfolded molecular beacon worked as a primer in the hybridization with the RCA template to start RCA, which could produce many long sequences of DNA containing amounts of adenines. The AuNPs were bound with the long-repeated adenine in the RCA product, causing accumulation of AuNPs on the surface of the electrode. It was indicated that the spectral characteristics of adenine at 736 cm Show less
no PDF DOI: 10.1016/j.talanta.2022.123402
APOA4
Zimiao Luo, Linwei Lu, Weixia Xu +7 more · 2022 · Journal of controlled release : official journal of the Controlled Release Society · Elsevier · added 2026-04-24
Chemotherapy is still the mainstay treatment for metastatic triple-negative breast cancers (TNBC) currently in clinical practice. The unmet needs of chemotherapy for metastatic TNBC are mainly from th Show more
Chemotherapy is still the mainstay treatment for metastatic triple-negative breast cancers (TNBC) currently in clinical practice. The unmet needs of chemotherapy for metastatic TNBC are mainly from the insufficient drug delivery and unavailable targeting strategy that thwart the whole progression of metastatic TNBC. The in vivo ligands-mediated active targeting efficiency is usually affected by protein corona. While, the protein corona-bridged natural targeting, in turn, provides a new way for specific drug delivery. Herein, we develop a novel metastatic progression-oriented in vivo self-assembled Cabazitaxel nanocrystals (CNC) delivery system (PC/CNC) through the CNC automatically absorbing functional plasma proteins (transferrin, apolipoprotein A-IV and apolipoprotein E) in vivo, aiming to achieve the simultaneously targeted delivery to primary tumors, circulating tumor cells and metastatic lesions. With the unique advantages of superhigh drug-loading and protein corona empowered active targeting properties to tumor cells, HUVECs, active-platelets and blood-brain barrier/blood-tumor barrier, the PC/CNC exhibits a significantly improved therapeutic effect in metastatic TNBC therapy compared with free drug and CNC-loaded liposomes. Show less
no PDF DOI: 10.1016/j.jconrel.2022.03.058
APOA4
Yanxiang Wu, Lianfeng Chen, Ziyan Xie +3 more · 2022 · Proteomics · Wiley · added 2026-04-24
ATP-binding cassette transporter G1 (ABCG1) is a cellular transmembrane protein that transports oxysterol efflux from cells to high-density lipoprotein (HDL) particles in the plasma. Previous studies Show more
ATP-binding cassette transporter G1 (ABCG1) is a cellular transmembrane protein that transports oxysterol efflux from cells to high-density lipoprotein (HDL) particles in the plasma. Previous studies have demonstrated that an ABCG1 deficiency exerts an antiatherosclerotic function through the effects of oxysterol accumulation in cells to enhance apoptosis and regulate inflammatory processes. However, whether the deficiency of ABCG1 and the corresponding changes in the efflux of oxysterols could take a series of impacts on the proteomic composition of HDL remains unclear. Here, plasma HDL of ABCG1(-/-) mice and their wild-type controls on a normal chow diet (NCD) or a high-fat diet (HFD) were isolated by ultracentrifugation. The proportion of 7-ketocholesterol and the proteomic composition of samples were comparatively analyzed by LC-MS/MS. In NCD-fed mice, lipid metabolism-related protein (arachidonate 12-lipoxygenase) and antioxidative protein (pantetheinase) exhibited increased accumulation, and inflammatory response protein (alpha-1-antitrypsin) was decreased in accumulation in ABCG1(-/-) mice HDL. In HFD-fed mice, fewer proteins were detected than that of NCD-fed mice. The ABCG1(-/-) mice HDL exhibited increased accumulation of lipid metabolism-related proteins (e.g., carboxylesterase 1C, apolipoprotein (apo)C-4) and decreased accumulation of alpha-1-antitrypsin, as well as significantly reduced proportion of 7-ketocholesterol. Additionally, positive correlations were found between 7-ketocholesterol and some essential proteins on HDL, such as alpha-1-antitrypsin, apoA-4, apoB-100, and serum amyloid A (SAA). These results suggest a detrimental impact of oxysterols on HDL composition, which might affect the antiatherosclerotic properties of HDL. Show less
no PDF DOI: 10.1002/pmic.202100028
APOA4
Kexin Ding, Zechen Zhou, Yujia Ma +5 more · 2022 · Biomedicines · MDPI · added 2026-04-24
The aggregation and interaction of metabolic risk factors leads to highly heterogeneous pathogeneses, manifestations, and outcomes, hindering risk stratification and targeted management. To deconstruc Show more
The aggregation and interaction of metabolic risk factors leads to highly heterogeneous pathogeneses, manifestations, and outcomes, hindering risk stratification and targeted management. To deconstruct the heterogeneity, we used baseline data from phase II of the Fangshan Family-Based Ischemic Stroke Study (FISSIC), and a total of 4632 participants were included. A total of 732 individuals who did not have any component of metabolic syndrome (MetS) were set as a reference group, while 3900 individuals with metabolic abnormalities were clustered into subtypes using multi-trait limited mixed regression (MFMR). Four metabolic subtypes were identified with the dominant characteristics of abdominal obesity, hypertension, hyperglycemia, and dyslipidemia. Multivariate logistic regression showed that the hyperglycemia-dominant subtype had the highest coronary heart disease (CHD) risk (OR: 6.440, 95% CI: 3.177-13.977) and that the dyslipidemia-dominant subtype had the highest stroke risk (OR: 2.450, 95% CI: 1.250-5.265). Exome-wide association studies (EWASs) identified eight SNPs related to the dyslipidemia-dominant subtype with genome-wide significance, which were located in the genes Show less
📄 PDF DOI: 10.3390/biomedicines10123093
APOA5
Di Wu, Jiheng Wang, Yongxing Chang +6 more · 2022 · Obesity (Silver Spring, Md.) · Wiley · added 2026-04-24
Lipid metabolic disorders pose a serious threat to human health, and currently no good treatments exist. In earlier studies by the authors, HepG2 cells with diacylglycerol kinase theta (DGKθ) knockout Show more
Lipid metabolic disorders pose a serious threat to human health, and currently no good treatments exist. In earlier studies by the authors, HepG2 cells with diacylglycerol kinase theta (DGKθ) knockout were found to cause significant lipid accumulation, suggesting that DGKθ may be a potential target for treating lipid metabolic disorders. A high-throughput screening of natural products targeting the potential signaling pathway of lipid metabolism was carried out in the DGKθ-T2A-luciferase knock-in HepG2 cell. RNA-sequencing and bioinformatic approaches were used to analyze the potential pathway by which rutaecarpin decreases lipids. Western blot and quantitative polymerase chain reaction were performed to investigate the mechanisms of rutaecarpin's reduction in lipid levels. Rutaecarpin was found to significantly enhance DGKθ expression, and the potential mechanisms by which rutaecarpin accelerates lipid metabolism by targeting DGKθ was explored in vitro and in vivo. The results indicated that rutaecarpin could markedly reduce lipid accumulation in oleic acid-induced HepG2 cells and in high-fat diet-induced obese C57BL/6J mice by targeting the hepatocyte nuclear factor 1-beta (HNF1B)-DGKθ-peroxisome proliferator-activated receptor alpha (PPARα)-apolipoprotein C3 (APOC3) pathway. Rutaecarpin is effective in reducing lipid accumulation, and the development of a high-throughput screening platform based on a reporter knock-in cell line may facilitate the discovery of effective drugs for lipid metabolic disorders based on the DGKθ target. Show less
no PDF DOI: 10.1002/oby.23572
APOC3
Peng Liu, Jianqiang Wu, Dandan Sun +6 more · 2022 · Frontiers in immunology · Frontiers · added 2026-04-24
We aimed to explore and identify candidate protein biomarkers of cryoglobulinemia (CGE) in disease control patients with negative cryoglobulin (DC) or healthy controls (HCs). The tandem mass tag (TMT) Show more
We aimed to explore and identify candidate protein biomarkers of cryoglobulinemia (CGE) in disease control patients with negative cryoglobulin (DC) or healthy controls (HCs). The tandem mass tag (TMT)-labeled serum quantitative proteomics approach was used to identify differentially expressed proteins between the CGE and DC groups. Ingenuity pathway analysis was used for functional annotation of differentially expressed proteins. Biomarker candidates were validated in another cohort using the parallel reaction monitoring (PRM) method. Apolipoprotein A1 (APOA1), apolipoprotein CIII (APOC3), adiponectin, and proprotein convertase subtilisin/kexin type-9 (PCSK9), which represent key proteins involved in the cholesterol metabolism pathway, were further verified in an increased number of samples by enzyme-linked immunosorbent assay (ELISA). A total of 1004 proteins were identified, of which 109 proteins were differentially expressed between the CGE and DC groups. These differentially expressed proteins were primarily involved in hepatic fibrosis/hepatic stellate cell activation and immune/inflammation-related pathways. In the disease and biofunction analysis, these proteins were mainly associated with the adhesion of blood cells, leukocyte migration, cholesterol transport, and transport of lipids. Twelve candidate biomarkers were validated by PRM-based proteomics, and proteins involved in the cholesterol metabolism pathway were further verified. APOA1, APOC3, adiponectin and PCSK9 concentrations were increased in CGE patients compared with healthy controls (P=0.0123, 0.1136, 0.5760, and 0.0019, respectively). This report describes the first application of a TMT-PRM-ELISA workflow to identify and validate CGE-specific biomarkers in serum. APOA1 and PCSK9 have been confirmed to be increased in CGE patients, demonstrating that proteins involved in cholesterol metabolism are also implicated in the development of CGE. These findings contribute to pathogenesis research and biomarker discovery in CGE. Show less
📄 PDF DOI: 10.3389/fimmu.2022.855513
APOC3
Long-Jiang Chen, Lun Wu, Wei Wang +4 more · 2022 · International journal of oncology · added 2026-04-24
Pancreatic cancer (PC) is a lethal type of cancer for which effective therapies are limited. Long non‑coding RNAs (lncRNAs) represent a critical type of regulator category, mediating the tumorigenesis Show more
Pancreatic cancer (PC) is a lethal type of cancer for which effective therapies are limited. Long non‑coding RNAs (lncRNAs) represent a critical type of regulator category, mediating the tumorigenesis and development of various tumor types, including PC. However, the expression patterns and functions of numerous lncRNAs in PC remain poorly understood. In the present study, linc01614 was identified as a PC‑related lncRNA. linc01614 was notably upregulated in PC tissues and cell lines and was associated with the poor disease‑free survival of patients with PC according to the analysis of The Cancer Genome Atlas‑derived datasets. Functionally, linc01614 knockdown suppressed PC cell proliferation, migration and invasion Show less
📄 PDF DOI: 10.3892/ijo.2022.5406
AXIN1
Li Peng, Yuwei Liu, Jing Chen +7 more · 2022 · BMC medical genomics · BioMed Central · added 2026-04-24
Aberrant alternative splicing (AS) contributes to tumor progression. Previous studies have shown that apurinic-apyrimidinic endonuclease-1 (APEX1) is involved in tumor progression. It is unknown wheth Show more
Aberrant alternative splicing (AS) contributes to tumor progression. Previous studies have shown that apurinic-apyrimidinic endonuclease-1 (APEX1) is involved in tumor progression. It is unknown whether APEX1 functions in tumor progression by regulation of AS. It is also unknown whether APEX1 can regulate non-small-cell lung cancer (NSCLC) proliferation and apoptosis. We analyzed APEX1 expression levels in 517 lung NSCLC samples from the TCGA (Cancer Genome Atlas) database. The impact of APEX1 over expression on A549 cell proliferation and apoptosis was detected by the methyl thiazolyl tetrazolium assay and by flow cytometry. The transcriptome of A549 cells with and without APEX1 over expression was determined by Illumina sequencing, followed by analysis of AS. RT-qPCR validated expression of APEX1-related genes in A549 cells. We have successfully applied RNA-seq technology to demonstrate APEX1 regulation of AS. APEX1 expression was shown to be upregulated in NSCLC samples and to reduce cell proliferation and induce apoptosis of A549 cells. In addition, APEX1 regulated AS of key tumorigenesis genes involved in cancer proliferation and apoptosis within MAPK and Wnt signaling pathways. Each of these pathways are involved in lung cancer progression. Furthermore, validated AS events regulated by APEX1 were in key tumorigenesis genes; AXIN1 (axis inhibition protein 1), GCNT2 (N-acetyl glucosaminyl transferase 2), and SMAD3 (SMAD Family Member 3). These genes encode signaling pathway transcription regulatory factors. We found that increased expression of APEX1 was an independent prognostic factor related to NSCLC progression. Therefore, APEX1 regulation of AS may serve as a molecular marker or therapeutic target for NSCLC treatment. Show less
📄 PDF DOI: 10.1186/s12920-022-01290-0
AXIN1
Min Wu, Guozhong Chen, Xiaowen Liao +2 more · 2022 · Drug development research · Wiley · added 2026-04-24
M6A reader YTH structural domain family 2 (YTHDF2) has been recognized to play an oncogenic role in numerous tumors, but its role in cervical cancer has not been extensively discussed yet. This paper Show more
M6A reader YTH structural domain family 2 (YTHDF2) has been recognized to play an oncogenic role in numerous tumors, but its role in cervical cancer has not been extensively discussed yet. This paper was designed to explore the role of YTHDF2 in cervical cancer and identify its underlying mechanism. The expression of YTHDF2 was first determined in cervical cancer cells by quantitative reverse-transcription polymerase chain reaction and western blot. Then, the migration, invasion, and epithelial-mesenchymal transition (EMT) process were observed in YTHDF2-knockdown Hela cells using wound healing, transwell and immunofluorescence assays. The cisplatin chemosensitivity of Hela cells was also investigated by assessing cell activity with cell counting kit-8 and TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling). After MeRIP-Seq assay and actinomycin D treatment to confirm the binding relationship between YTHDF2 and AXIN1, the migration, invasion, EMT process, and cisplatin chemosensitivity were assessed again in Hela cells silenced by YTHDF2 and AXIN1 or treated with Wnt agonist. YTHDF2 was increased in cervical cancer cells, and depletion of YTHDF2 led to reduced migration, invasion and EMT process but enhanced chemosensitivity of cisplatin in Hela cells. Furthermore, YTHDF2 could bind to and stabilize the expression of AXIN1. When the YTHDF2-knockdown Hela cells were further transfected with AXIN1 knockdown or treated with Wnt agonist, the effects of YTHDF2 knockdown on the migration, invasion and EMT process were partially abolished, together with reduced cisplatin chemosensitivity. To sum up, we reported that YTHDF2 interference could suppress the EMT of cervical cancer cells and enhance cisplatin chemosensitivity by regulating AXIN1. Show less
no PDF DOI: 10.1002/ddr.21942
AXIN1
Zhiguo Wang, Conghua Lu, Kejun Zhang +12 more · 2022 · Frontiers in molecular biosciences · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fmolb.2022.780200
AXIN1
Hwa-Shin Fang, Chih-Ying Chao, Chun-Chieh Wang +4 more · 2022 · Journal of movement disorders · added 2026-04-24
A meta-analysis of locus-based genome-wide association studies recently identified a relationship between AXIN1 and Parkinson's disease (PD). Few studies of Asian populations, however, have reported s Show more
A meta-analysis of locus-based genome-wide association studies recently identified a relationship between AXIN1 and Parkinson's disease (PD). Few studies of Asian populations, however, have reported such a genetic association. The influences of rs13337493, rs758033, and rs2361988, three PD-associated genetic variants of AXIN1, were investigated in the present study because AXIN1 is related to Wnt/β-catenin signaling. A total of 2,418 individuals were enrolled in our Taiwanese cohort for analysis of the genotypic and allelic frequency. Polymerase chain reaction-restriction fragment length polymorphism analysis was employed for rs13337493 genotyping, and the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) was used for rs758033 and rs2361988 genotyping in 672 patients with PD and 392 controls. Taiwan Biobank data of another 1,354 healthy controls were subjected to whole-genome sequencing performed using Illumina platforms at approximately 30× average depth. Our results revealed that rs758033 {odds ratios [OR] (95% confidence interval [CI]) = 0.267 [0.064, 0.795], p = 0.014} was associated with the risk of PD, and there was a trend toward a protective effect of rs2361988 (OR [95% CI] = 0.296 [0.071, 0.884], p = 0.026) under the recessive model. The TT genotype of rs758033 (OR [95% CI] = 0.271 [0.065, 0.805], p = 0.015) and the CC genotype of rs2361988 (OR [95% CI] = 0.305 [0.073, 0.913], p = 0.031) were less common in the PD group than in the non-PD group. Our findings indicate that the rs758033 and rs2361988 polymorphisms of AXIN1 may affect the risk of PD in the Taiwanese population. Show less
📄 PDF DOI: 10.14802/jmd.21073
AXIN1
Alberto Bertozzi, Chi-Chung Wu, Stefan Hans +2 more · 2022 · Developmental biology · Elsevier · added 2026-04-24
Zebrafish can achieve scar-free healing of heart injuries, and robustly replace all cardiomyocytes lost to injury via dedifferentiation and proliferation of mature cardiomyocytes. Previous studies sug Show more
Zebrafish can achieve scar-free healing of heart injuries, and robustly replace all cardiomyocytes lost to injury via dedifferentiation and proliferation of mature cardiomyocytes. Previous studies suggested that Wnt/β-catenin signaling is active in the injured zebrafish heart, where it induces fibrosis and prevents cardiomyocyte cell cycling. Here, via targeting the destruction complex of the Wnt/β-catenin pathway with pharmacological and genetic tools, we demonstrate that Wnt/β-catenin activity is required for cardiomyocyte proliferation and dedifferentiation, as well as for maturation of the scar during regeneration. Using cardiomyocyte-specific conditional inhibition of the pathway, we show that Wnt/β-catenin signaling acts cell-autonomously to promote cardiomyocyte proliferation. Our results stand in contrast to previous reports and rather support a model in which Wnt/β-catenin signaling plays a positive role during heart regeneration in zebrafish. Show less
no PDF DOI: 10.1016/j.ydbio.2021.11.001
AXIN1
Anyao Bi, Junyong Wu, Shuai Huang +6 more · 2022 · Biomaterials research · BioMed Central · added 2026-04-24
β-Secretase (BACE1) is the vital enzyme in the pathogenic processes of Alzheimer's disease (AD). However, the development of a powerful tool with sensitivity for BACE1 determination in vivo is a chall Show more
β-Secretase (BACE1) is the vital enzyme in the pathogenic processes of Alzheimer's disease (AD). However, the development of a powerful tool with sensitivity for BACE1 determination in vivo is a challenge. A novel NIR fluorescent probe HBAE was synthetized from 2-hydroxy-3-methylbenzaldehyde and 2-amino-benzenethiol by 5 steps. The fluorescence mechanism in the ESIPT systems of HBAE probe was insighted with time-dependent density functional theory (TD-DFT) at the TDPBE0 level with the def2-TZVP approach. The corresponding docking between HBAE and BACE1 (PDB: 5I3Y) was performed through the ducking method by DOCK6.8. Then the BBB permeability of HBAE is verified by transwell orifice plate. 22-month-old male AD-model (5XFAD) mice and age-matched wild-type mice were employed to observe the brain kinetics by intravenous injection. Finally, Immunohistochemistry was performed on the AD brain section to reveal the levels of BACE1 in hippocampus and cortex areas and other regions in AD mice through the brain tissue slices by HBAE. The NIR fluorescent probe HBAE was successfully applied in imaging BACE1 in AD model mice. The capability of HBAE in reflecting different level of BACE1 was performed by the specific imaging of the hippocampus region. We reported the first ESIPT near-infrared fluorescence probe HBAE for monitoring endogenous BACE1 in the AD live model mice, thus offering a versatile chemical tool for visualizing in the pathological processes of AD live brains. Remarkably, high resolution images showed the localization of red fluorescence stains in hippocampus of the AD brain. This study provides a promising way for functional insights from protein BACE1 in vivo. Show less
📄 PDF DOI: 10.1186/s40824-022-00320-3
BACE1
Qing-Yuan Wang, He-Ping Chen, Kai-Yue Wu +2 more · 2022 · Frontiers in microbiology · Frontiers · added 2026-04-24
One new prenylated benzenoid, (±)-chevalieric acid (
📄 PDF DOI: 10.3389/fmicb.2022.1051281
BACE1
Mengshi Wang, Fei Lin, Xiaoying Zhang +6 more · 2022 · Journal of chemical neuroanatomy · Elsevier · added 2026-04-24
Being the most common form of dementia, Alzheimer's disease (AD) has a series of modifiable risk factors, including metal ions represented by aluminium. Aluminium (Al) exhibits its neurotoxic effects, Show more
Being the most common form of dementia, Alzheimer's disease (AD) has a series of modifiable risk factors, including metal ions represented by aluminium. Aluminium (Al) exhibits its neurotoxic effects, especially mainly by affecting amyloid-β protein (Aβ) aggregation and Tau hyperphosphorylation. As reported in our previous study, the combination of Alpinia Oxyphylla Fructus and Schisandra Chinensis Fructus (AS) had a neuroprotective effect. This study aimed to evaluate the anti-AD effect of AS and the mechanism by which AS reduces the neurotoxic effect of Al. Firstly, we used aluminium-maltol (Al(mal) Show less
no PDF DOI: 10.1016/j.jchemneu.2022.102180
BACE1
Qian Guo, Gang Wu, Fang Huang +7 more · 2022 · Aging · Impact Journals · added 2026-04-24
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia, characterized by cognitive deficits and memory dysfunction, which is clinically incurable so far. Novel small molecular Show more
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia, characterized by cognitive deficits and memory dysfunction, which is clinically incurable so far. Novel small molecular compound 2JY-OBZ4 is one of structural analogue of Huperzine A (Hup-A), an anti-AD drug in China. In our previous work, 2JY-OBZ4 exhibited potent effects on tau hyperphosphorylation, Aβ production and acetylcholinesterase (AChE) activity. However, 2JY-OBZ4's anti-AD effects and the underlying molecular mechanisms remain unclear. We here reported that 2JY-OBZ4 resisted tau hyperphosphorylation at Thr181 and Ser396 sites in HEK293-hTau cells transfected with GSK-3β, decreased tau phosphorylation via upregulating the activity of PP2A in HEK293-hTau cells and reduced Aβ production through regulating protein levels of APP cleavage enzymes in N2a-hAPP cells. Meanwhile, we found that 2JY-OBZ4 had no adverse effects on cell viability of mice primary neuron even at high concentration, and ameliorated synaptic loss induced by human oligomeric Aβ42. 2JY-OBZ4 had moderate AChE inhibitory activity with the half maximal inhibitory concentration (IC50) to be 39.48 μg/ml Show less
📄 PDF DOI: 10.18632/aging.204336
BACE1
Nan Wang, Wenjie Liu, Lijun Zhou +11 more · 2022 · ACS omega · ACS Publications · added 2026-04-24
The pathogenesis of Alzheimer's disease (AD) is very complex, and there are many hypotheses. Therefore, the development of a multi-target-directed-ligand may be an effective therapeutic strategy. Our Show more
The pathogenesis of Alzheimer's disease (AD) is very complex, and there are many hypotheses. Therefore, the development of a multi-target-directed-ligand may be an effective therapeutic strategy. Our previous study showed that notopterol (a natural product from Show less
📄 PDF DOI: 10.1021/acsomega.2c03368
BACE1
Qiong Wu, Xiang Li, Xiao-Wen Jiang +6 more · 2022 · Frontiers in pharmacology · Frontiers · added 2026-04-24
Yuan-Zhi Decoction (YZD) is a traditional Chinese medical formulation with demonstrated clinical benefits in Alzheimer's disease (AD). We used liquid chromatography coupled with mass spectrometry to i Show more
Yuan-Zhi Decoction (YZD) is a traditional Chinese medical formulation with demonstrated clinical benefits in Alzheimer's disease (AD). We used liquid chromatography coupled with mass spectrometry to identify 27 unique chemical components of YZD. Analyzing these using network pharmacology and molecular docking models identified 34 potential interacting molecular targets involved in 26 biochemical pathways. When tested in an animal model of AD, the APP/PS1 transgenic mice showed measurable improvements in spatial orientation and memory after the administration of YZD. These improvements coincided with significantly reduced deposition of Aβ plaques and tau protein in the hippocampi in the treated animals. In addition, a decreased BACE1 and beta-amyloid levels, a downregulation of the p-GSK-3β/GSK-3β, and an upregulation of the PI3K and p-AKT/AKT pathway was seen in YZD treated animals. These Show less
📄 PDF DOI: 10.3389/fphar.2022.893244
BACE1
Xinyan Wu, Xiaomei Zheng, Huaqiao Tang +7 more · 2022 · Medicine · added 2026-04-24
Alzheimer disease (AD) is a degenerative brain disease, which may lead to severe memory loss and other cognitive disorders. However, few effective drugs are available in the clinic at present. Curcumi Show more
Alzheimer disease (AD) is a degenerative brain disease, which may lead to severe memory loss and other cognitive disorders. However, few effective drugs are available in the clinic at present. Curcumin, a major ingredient of traditional Chinese medicine, Curcuma Longa, has various pharmacological activities. Therefore, exploring clinical drugs based on the inhibition of AD pathological features is imperative. First, we utilized the HERB database and Swisstarget Prediction database to get the related targets of curcumin and intersected with the AD targets. The intersection targets were used to construct the protein-protein interaction network and performed gene ontology and kyoto encyclopedia of genes and genomes analyses. Further, we obtained targets of curcumin against AD-related tau and aβ pathology via the AlzData database. These targets were applied to perform GEO and receiver operating characteristic analyses. Finally, the reliability of the core targets was evaluated using molecular docking technology. We identified 49 targets of curcumin against AD, and kyoto encyclopedia of genes and genomes pathway enrichment analysis demonstrated that the Alzheimer disease pathway (has05010) was significantly enriched. Even more, we obtained 16 targets of curcumin-related Aβ and tau pathology. Among these targets, 8 targets involved the Alzheimer disease pathway and the biological process analyses showed that positive regulation of cytokine production (GO:0001819) was significantly enriched. Bioinformatic analyses indicated that HMOX1, CSF1R, NFKB1, GSK3B, BACE1, AR, or PTGS1 expression was significantly different compared to the control group in the AD patients. Finally, molecular docking studies suggested these genes have a good binding force with curcumin. In this study, we identified curcumin exerted the effect of treating AD by regulating multitargets and multichannels through the method of network pharmacology. Show less
📄 PDF DOI: 10.1097/MD.0000000000030194
BACE1
Wenjie Liu, Limeng Wu, Wenwu Liu +10 more · 2022 · European journal of medicinal chemistry · Elsevier · added 2026-04-24
Multi-targeted directed ligands (MTDLs) are emerging as promising Alzheimer's disease (AD) therapeutic possibilities. Coumarin is a multifunctional backbone with extensive bioactivity that has been ut Show more
Multi-targeted directed ligands (MTDLs) are emerging as promising Alzheimer's disease (AD) therapeutic possibilities. Coumarin is a multifunctional backbone with extensive bioactivity that has been utilized to develop innovative anti-neurodegenerative properties and is a desirable starting point for the construction of MTDLs. Herein, we explored and synthesized a series of novel coumarin derivatives and assessed their inhibitory effects on cholinesterase (AChE, BuChE), GSK-3β, and BACE1. Among these compounds, compound 30 displayed the multifunctional profile of targeting the AChE (IC Show less
no PDF DOI: 10.1016/j.ejmech.2022.114689
BACE1
Quan Yuan, Yiran Wu, Gang Wang +5 more · 2022 · Metabolic brain disease · Springer · added 2026-04-24
Arctigenin (Arc) is a phenylpropanoid dibenzylbutyrolactone lignan in Arctium lappa L, which has been widely applied as a traditional Chinese herbal medicine for treating inflammation. In the present Show more
Arctigenin (Arc) is a phenylpropanoid dibenzylbutyrolactone lignan in Arctium lappa L, which has been widely applied as a traditional Chinese herbal medicine for treating inflammation. In the present study, we explored the neuroprotective effect and the potential mechanisms of arctigenin against LPS-evoked neuroinflammation, neurodegeneration, and memory impairments in the mice hippocampus. Daily administration of arctigenin (50 mg/kg per day, i.g.) for 28 days revealed noticeable improvements in spatial learning and memory deficits after exposure to LPS treatment. Arctigenin prevented LPS-induced neuronal/synaptic injury and inhibited the increases in Abeta (Aβ) generation and the levels of amyloid precursor protein (APP) and β-site amyloid precursor protein cleavage enzyme 1 (BACE1). Moreover, arctigenin treatment also suppressed glial activation and reduced the production of proinflammatory cytokines. In LPS-treated BV-2 microglial cells and mice, activation of the TLR4 mediated NF-κB signaling pathway was significantly suppressed by arctigenin administration. Mechanistically, arctigenin reduced the LPS-induced interaction of adiponectin receptor 1 (AdipoR1) with TLR4 and its coreceptor CD14 and inhibited the TLR4-mediated downstream inflammatory response. The outcomes of the current study indicate that arctigenin mitigates LPS-induced apoptotic neurodegeneration, amyloidogenesis and neuroinflammation as well as cognitive impairments, and suggest that arctigenin may be a potential therapeutic candidate for neuroinflammation/neurodegeneration-related diseases. Show less
no PDF DOI: 10.1007/s11011-022-01031-3
BACE1
Li-Ping Huang, Xiao-Qin Zhong, Xin-Yu Zhou +3 more · 2022 · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · added 2026-04-24
The study aimed to investigate the effects of galangin on learning and memory impairments and Akt/MEF2 D/Beclin-1 signaling pathway in APP/PS1 double-transgenic mice. The mice in this experiment were Show more
The study aimed to investigate the effects of galangin on learning and memory impairments and Akt/MEF2 D/Beclin-1 signaling pathway in APP/PS1 double-transgenic mice. The mice in this experiment were divided into the normal group, model group, low-(25 mg·kg~(-1)), medium-(50 mg·kg~(-1)), and high-dose(100 mg·kg~(-1)) galangin groups, donepezil(3 mg·kg~(-1)) group, Akt inhibitor(25 mg·kg~(-1)) group, and autophagy inhibitor(30 mg·kg~(-1)) group, with ten in each group, and administered with the corresponding drugs for 30 successive days. On the 24 th day of medication, the water maze and dark avoidance tests were performed. The levels of p-tau, β-amyloid peptide 1-42(Aβ₍₄₂₎₎, acetylcholinesterase(AChE), β-site amyloid precursor protein cleaving enzyme 1(BACE1), and amyloid precursor protein(APP) in hippocampus were detected by ELISA, the Beclin-1 mRNA expression by RT-PCR, the expression of Aβ₍₄₂₎ and glial fibrillary acidic protein(GFAP) by immunohistochemistry, and the expression of myocyte enhancer factor 2 D(MEF2 D) by immunofluorescence assay. The pathological changes in hippocampus were observed after HE staining, and the expression of Akt, MEF2 D, and Beclin-1 in hippocampus were assayed by Western blot. These results showed that compared with the normal group, the model group exhibited prolonged swimming time, increased number of errors and electric shocks, up-regulated p-tau, Aβ₍₄₂₎, APP, AChE, BACE1, GFAP, and Beclin-1, shortened incubation period, decreased p-Akt and MEF2 D, and obvious hippocampal injury. Compared with the model group, donepezil and galangin shortened the swimming time, reduced the number of errors and electric shocks, down-regulated the expression of p-tau, Aβ₍₄₂₎, APP, AChE, BACE1, GFAP, and Beclin-1, prolonged the incubation period, up-regulated p-Akt and MEF2 D, and improved the pathological changes in hippocampus. Compared with the autophagy inhibitor group, galangin prolonged the swimming time, elevated the number of errors and electric shocks, enhanced the expression of p-tau, Aβ₍₄₂₎, APP, AChE, BACE1, GFAP, and Beclin-1, shortened the incubation period, and diminished the expression of p-Akt and MEF2 D. In conclusion, galangin improves the learning and memory impairments and hippocampal neuron injury of APP/PS1 mice, which may be related to its regulation of Akt/MEF2 D/Beclin-1 signaling pathway. Show less
no PDF DOI: 10.19540/j.cnki.cjcmm.20211117.705
BACE1
Liang Gu, Nan Cai, Meiting Li +9 more · 2022 · Frontiers in nutrition · Frontiers · added 2026-04-24
Alzheimer's disease (AD) is a neurodegenerative disorder mainly affecting old population. In this study, two Tau overexpressing cell lines (SH-SY5Y/Tau and HEK293/Tau), N2a/SweAPP cell line, and 3× Tr Show more
Alzheimer's disease (AD) is a neurodegenerative disorder mainly affecting old population. In this study, two Tau overexpressing cell lines (SH-SY5Y/Tau and HEK293/Tau), N2a/SweAPP cell line, and 3× Transgene (APPswe/PS1M146V/TauP301L) mouse primary nerve cell lines were used as AD models to study the activity and molecular mechanism of macelignan, a natural compound extracted from Show less
📄 PDF DOI: 10.3389/fnut.2022.892558
BACE1